REPURPOSING PHARMACEUTICALS: DOES UNITED STATES INTELLECTUAL PROPERTY LAW AND REGULATORY POLICY ASSIGN SUFFICIENT VALUE TO NEW USE PATENTS?

Thomas A. Hemphill ()

International Journal of Innovation Management (ijim), 2012, vol. 16, issue 04, 1-17

Abstract: No abstract received.

Date: 2012
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
http://www.worldscientific.com/doi/abs/10.1142/S1363919611003659
Access to full text is restricted to subscribers

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:wsi:ijimxx:v:16:y:2012:i:04:n:s1363919611003659

Ordering information: This journal article can be ordered from

DOI: 10.1142/S1363919611003659

Access Statistics for this article

International Journal of Innovation Management (ijim) is currently edited by Joe Tidd

More articles in International Journal of Innovation Management (ijim) from World Scientific Publishing Co. Pte. Ltd.
Bibliographic data for series maintained by Tai Tone Lim ().